PROTEASE INHIBITOR (PI)
Prezista is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications in people three years or older. Prezista is also referred to by its drug name, Darunavir, and by the abbreviation DRV. Darunavir is a component of the combination drug Prezcobix.
Prezista is an antiviral medication of the protease inhibitor (PI) class. Prezista is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Prezista is taken once or twice daily.
Prezista comes in tablet and oral suspension forms.
The FDA-approved label for Prezista lists common side effects including headache, nausea, vomiting, diarrhea, stomach pain, heartburn, rash, weakness, and changes in the shape or location of body fat.
Rare but serious side effects listed for Prezista include severe skin reactions and jaundice.
For more details about this treatment, visit:
Prezista – RxList
Overview of HIV Treatments – AIDS.gov